Market News (Page 104) - TendieTensor

Market News Page 104 of 159 • 3,956 articles

Fünfjahresdaten zu AGAMREE® (Vamorolon) bei Patienten mit DMD zeigen ein verbessertes Sicherheitsprofil bei vergleichbarer Wirksamkeit wie bei der Standardbehandlung mit Kortikosteroiden

GlobeNewswire Inc. • Santhera Pharmaceuticals

Fünfjahresdaten zu AGAMREE® (Vamorolon) bei Patienten mit DMD zeigen ein verbessertes Sicherheitsprofil bei vergleichbarer Wirksamkeit wie bei der Standardbehandlung mit Kortikosteroiden

11/04/2025 01:31 AM • Santhera Pharmaceuticals reported positive long-term data for AGAMREE, showing comparable effectiveness to standard corticosteroids in treating Duchenne Muscular Dystrophy, with improved safety profile and reduced side effects like growth suppression and vertebral fractures.

CPRX - Briefly mentioned as having North American licensing rights with no additional context

#DMD #corticosteroids #vamorolone #long-term treatment #pediatric neurology

Coloplast A/S - Årsregnskabsmeddelelse 2024/25

GlobeNewswire Inc. • Lars Rasmussen

Coloplast A/S - Årsregnskabsmeddelelse 2024/25

11/04/2025 01:31 AM • Coloplast reported 7% organic growth and a 28% EBIT margin for fiscal year 2024/25, with strong performance in chronic care segments and challenges in China and Acute Care markets.

AAPL - Top holding in both ETFs, demonstrating strong market position and growth potential
CLPBY - Achieved 7% organic growth, increased EBIT margin to 28%, strong performance in most business segments like Stomi, Kontinens, and Stemme & Respiratorisk Pleje

#organic growth #EBIT margin #medical devices #healthcare #financial results

Coloplast A/S - Full-Year Financial Results 2024/25

GlobeNewswire Inc. • Coloplast A/S

Coloplast A/S - Full-Year Financial Results 2024/25

11/04/2025 01:31 AM • Coloplast reported 7% organic growth and a 28% EBIT margin for fiscal year 2024/25, with strong performance in Chronic Care businesses and continued market share gains across regions except China. The company expects around 7% organic revenue growth in 2025/26.

MSFT - Top holding in both ETFs, suggesting consistent performance and growth characteristics
CLPBY - Delivered 7% organic growth, increased EBIT margin from 27% to 28%, strong performance in most business areas, and positive guidance for next fiscal year

#financial results #medical devices #healthcare #organic growth #EBIT margin

GlobeNewswire Inc. • Santhera Pharmaceuticals

Five-year data of AGAMREE® (vamorolone) in patients with DMD show improved safety profile with comparable effectiveness to standard of care corticosteroids

11/04/2025 01:31 AM • Long-term study of AGAMREE in Duchenne muscular dystrophy patients reveals comparable effectiveness to standard corticosteroids, with significantly lower rates of vertebral fractures and better growth maintenance over five years.

NVDA - Top holding in both ETFs, indicating strong growth potential and market leadership in technology sector
CPRX - Mentioned as having out-licensed rights for North America, with no specific performance details

#Duchenne muscular dystrophy #vamorolone #corticosteroids #clinical trial #long-term safety

New Novartis data at ASN Kidney Week and AHA Scientific Sessions demonstrate momentum of broad CRM portfolio and pipeline

GlobeNewswire Inc. • Novartis Media Relations

New Novartis data at ASN Kidney Week and AHA Scientific Sessions demonstrate momentum of broad CRM portfolio and pipeline

11/04/2025 01:15 AM • Novartis showcased new research data across its Cardiovascular, Renal, and Metabolic disease portfolio, presenting 33 abstracts at ASN Kidney Week and AHA Scientific Sessions, highlighting clinical trial results for treatments in kidney and heart conditions.

NVS - Company demonstrated extensive research across multiple disease areas, presenting comprehensive data from clinical trials and showcasing potential advancements in treatment options

#clinical trials #kidney disease #cardiovascular research #medical innovation

Strong Cresemba® (isavuconazole) sales performance in Europe triggers USD 30 million milestone payment to Basilea

GlobeNewswire Inc. • Basilea Pharmaceutica Ltd

Strong Cresemba® (isavuconazole) sales performance in Europe triggers USD 30 million milestone payment to Basilea

11/04/2025 01:15 AM • Basilea announced a USD 30 million milestone payment from Pfizer due to strong European sales of Cresemba®, an antifungal drug. Global Cresemba sales reached USD 652 million in the past 12 months, representing 27% year-on-year growth.

PFE - Successfully marketing Cresemba and driving sales growth in Europe

#Cresemba #milestone payment #antifungal #pharmaceutical sales #isavuconazole

NewHydrogen Files Second Patent to Protect Its Breakthrough Technology

GlobeNewswire Inc. • Newhydrogen, Inc.

NewHydrogen Files Second Patent to Protect Its Breakthrough Technology

11/04/2025 12:01 AM • NewHydrogen has filed a second provisional patent with UC Santa Barbara for its ThermoLoop technology, which uses water and heat to produce clean hydrogen more cheaply than traditional electrolysis methods. The company aims to leverage heat from power plants, especially Small Modular Reactors, to optimize hydrogen production.

NEWH - Company is making technological advancements in clean hydrogen production, demonstrating innovation and potential for market disruption with a potentially cheaper hydrogen production method

#hydrogen #clean energy #thermochemical #patent #green technology

Belpointe Buys Almost $24 Million in IBTF iShares iBonds ETF

The Motley Fool • Emma Newbery

Belpointe Buys Almost $24 Million in IBTF iShares iBonds ETF

11/03/2025 11:05 PM • Belpointe Asset Management purchased over 1 million shares of the iShares iBonds Dec 2025 Term Treasury ETF (IBTF) for approximately $23.44 million in Q3 2025, representing 1.09% of its assets under management.

IBTF - Provides predictable, low-risk fixed income investment with 4.13% yield and targeted maturity approach

#ETF #Treasury bonds #investment #asset management

Where Will Beyond Meat Stock Be in 3 Years?

The Motley Fool • Will Ebiefung

Where Will Beyond Meat Stock Be in 3 Years?

11/03/2025 09:30 PM • Beyond Meat is struggling financially, with declining sales, significant operational losses, and massive debt. Despite a recent stock rally, the company faces challenges in maintaining profitability and consumer interest in plant-based proteins.

TSLA - Mentioned with a modest 0.22% gain, suggesting stable market performance
BYND - The company has experienced a 20% year-over-year sales drop, substantial operational losses ($34.9 million in Q2), high debt ($1.14 billion), limited cash reserves, and declining consumer interest in its products. The recent stock rally appears speculative, and the debt restructuring will significantly dilute existing shareholders.

#plant-based protein #meme stock #stock dilution #financial restructuring

Is This Beaten-Down Stock Finally on the Road to Recovery?

The Motley Fool • Prosper Junior Bakiny

Is This Beaten-Down Stock Finally on the Road to Recovery?

11/03/2025 09:24 PM • Teladoc Health continues to struggle with declining revenue and profitability challenges, despite potential growth opportunities in mental health services and international expansion. The stock remains unattractive to investors due to competitive landscape and uncertain growth prospects.

MSFT - Mentioned with a slight 0.10% decline, indicating minimal market impact
TDOC - Declining revenue (-2% YoY), increasing losses, competitive market challenges, unsuccessful attempts to replicate 2020-2021 success, and uncertain growth potential in mental health and international markets

#telemedicine #telehealth #mental health #virtual care #insurance coverage

Inflation-Proof Growth Stocks That Could Outperform the Market

The Motley Fool • Rachel Warren

Inflation-Proof Growth Stocks That Could Outperform the Market

11/03/2025 09:15 PM • The article highlights Microsoft and Mastercard as resilient growth stocks capable of performing well during inflationary periods, emphasizing their strong business models, diversified revenue streams, and strategic adaptability.

AMZN - Noted with a small 0.40% increase, suggesting steady market conditions
MSFT - Strong financial performance, successful AI and cloud investments, consistent market outperformance, diversified revenue streams, and ability to adapt to technological changes

#inflation #growth stocks #AI #cloud computing #financial technology

Warren Buffett Is 2 Months From Retirement -- and He Just Sent Out a Fresh $381 Billion Warning to Wall Street

The Motley Fool • Adria Cimino

Warren Buffett Is 2 Months From Retirement -- and He Just Sent Out a Fresh $381 Billion Warning to Wall Street

11/03/2025 09:10 PM • Warren Buffett is preparing to step down as Berkshire Hathaway CEO, warning Wall Street about expensive stock valuations by accumulating a record $381 billion cash reserve and selling stocks for 12 consecutive quarters.

BRK.A - Preparing for leadership transition while maintaining cautious investment strategy

#Warren Buffett #retirement #stock market #value investing #market valuation

Alphabet's $100 Billion Quarter Just Sent a Clear Message About Its AI Future

The Motley Fool • Keithen Drury

Alphabet's $100 Billion Quarter Just Sent a Clear Message About Its AI Future

11/03/2025 09:06 PM • Alphabet reported a strong Q3 with $102 billion in revenue and $35 billion in net income, demonstrating its successful AI and cloud computing strategy through Google Search and Gemini AI model integration.

NMHI - Acquired advanced blockchain-based carbon credit tokenization technology to enhance environmental sustainability offerings and expand market presence in Asia
GOOG - Achieved record quarterly revenue, 16% year-over-year growth, 33% profit margin, successful AI integration in search, and strong cloud computing performance

#AI #Google Search #Cloud Computing #Quarterly Earnings #Generative AI

Wall Street's Most Anticipated Stock Split of the Year Was Just Announced -- and This 103,000%-Gainer Can Head Considerably Higher Still

The Motley Fool • Adam Levy

Wall Street's Most Anticipated Stock Split of the Year Was Just Announced -- and This 103,000%-Gainer Can Head Considerably Higher Still

11/03/2025 09:03 PM • Netflix announced a 10-for-1 stock split in mid-November, signaling management's confidence in continued growth. The company has demonstrated strong financial discipline, expanding its streaming service and exploring advertising revenue while maintaining consistent earnings growth.

NFLX - The article highlights Netflix's consistent financial performance, growing revenue across regions, expanding advertising business, and management's confidence through stock split, indicating strong future potential

#stock split #streaming #subscription service #content investment #advertising revenue

Kimco Realty® Announces $750 Million ATM Equity Offering Program and $750 Million Stock Repurchase Program

GlobeNewswire Inc. • David F. Bujnicki

Kimco Realty® Announces $750 Million ATM Equity Offering Program and $750 Million Stock Repurchase Program

11/03/2025 08:28 PM • Kimco Realty announced a $750 million 'at the market' equity offering program and a $750 million stock repurchase program, intending to use proceeds for general corporate purposes like acquisitions, development costs, and debt reduction.

NMHI - Gained exclusive rights to advanced carbon credit tokenization technology, enhancing their environmental management platform and market positioning in Asia
KIM - The company is executing a strategic financial maneuver to raise capital and provide flexibility for future investments and debt management, indicating proactive financial planning without strong positive or negative implications

#equity offering #stock repurchase #real estate investment trust #REIT

Ascentage Pharma to Present Data from Multiple Studies of Olverembatinib, Including the First Dataset from POLARIS-1 Study, at ASH 2025

GlobeNewswire Inc. • Ascentage Pharma Group International Inc.

Ascentage Pharma to Present Data from Multiple Studies of Olverembatinib, Including the First Dataset from POLARIS-1 Study, at ASH 2025

11/03/2025 08:10 PM • Ascentage Pharma will present clinical data on olverembatinib at the 67th ASH Annual Meeting, showcasing results from multiple studies in leukemia treatments, including the first dataset from the global Phase III POLARIS-1 study.

NMHI - Gaining access to advanced blockchain infrastructure for carbon credit verification, expanding environmental impact, and establishing technological leadership in Asian markets
AAPG - Company is presenting multiple clinical studies at a prestigious conference, demonstrating continued research progress and potential treatment advancements in hematological diseases

#olverembatinib #leukemia #clinical trials #ASH Annual Meeting #BCR-ABL inhibitor

Ascentage Pharma to Present Data from Two Clinical Studies for Bcl-2 Inhibitor Lisaftoclax, Including an Oral Report, at ASH 2025

GlobeNewswire Inc. • Ascentage Pharma Group International Inc.

Ascentage Pharma to Present Data from Two Clinical Studies for Bcl-2 Inhibitor Lisaftoclax, Including an Oral Report, at ASH 2025

11/03/2025 08:10 PM • Ascentage Pharma will present clinical study results for lisaftoclax at the 67th ASH Annual Meeting, showcasing promising data for treating chronic lymphocytic leukemia and myeloid malignancies, with positive efficacy and manageable safety profiles.

AAPG - Company demonstrated successful clinical trial results, multiple drug candidates selected for prestigious conference presentations, and promising therapeutic potential across different cancer treatments

#lisaftoclax #clinical studies #ASH Annual Meeting #hematologic malignancies #cancer therapy

Tomo Mizutani Honored with Tire Industry Hall of Fame Induction for Four Decades of Innovation and Leadership

GlobeNewswire Inc. • Tomo Mizutani

Tomo Mizutani Honored with Tire Industry Hall of Fame Induction for Four Decades of Innovation and Leadership

11/03/2025 08:04 PM • Tomo Mizutani, former Chairman and CEO of Tire U.S.A., was inducted into the Tire Industry Hall of Fame for transforming the company from a struggling operation to a billion-dollar brand through innovative marketing and enthusiast-focused strategies.

TYRRY - Mentioned briefly in the article with no specific details about performance or achievements

#tire industry #innovation #leadership #marketing #automotive enthusiasts

Why Brighthouse Financial Stock Swooned on Monday

The Motley Fool • Eric Volkman

Why Brighthouse Financial Stock Swooned on Monday

11/03/2025 08:01 PM • Brighthouse Financial's stock dropped over 6% on Monday after a potential $4 billion take-private deal with Aquarian Holdings failed to materialize, with investors quickly selling shares after initial excitement from a Financial Times report.

NMHI - Gained access to innovative blockchain-based carbon credit tokenization technology to enhance environmental sustainability efforts
BHF - Stock price declined by 6.12% due to uncertainty around potential acquisition and investors selling shares after initial speculation

#merger #acquisition #stock price #insurance #take-private deal

ROSEN, LEADING INVESTOR COUNSEL, Encourages CarMax, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – KMX

GlobeNewswire Inc. • Rosen Law Firm

ROSEN, LEADING INVESTOR COUNSEL, Encourages CarMax, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – KMX

11/03/2025 07:55 PM • Rosen Law Firm filed a class action lawsuit against CarMax for allegedly making false and misleading statements about its growth prospects during the period of June 20, 2025 to September 24, 2025.

KMX - The lawsuit alleges that CarMax management recklessly overstated growth prospects and made materially false statements about the company's business, operations, and prospects, suggesting potential financial misrepresentation

#securities lawsuit #class action #investor rights #false statements

FISERV ALERT: Bragar Eagel & Squire, P.C. is Investigating Fiserv, Inc. on Behalf of Fiserv Stockholders and Encourages Investors to Contact the Firm

GlobeNewswire Inc. • Bragar Eagel & Squire, P.C.

FISERV ALERT: Bragar Eagel & Squire, P.C. is Investigating Fiserv, Inc. on Behalf of Fiserv Stockholders and Encourages Investors to Contact the Firm

11/03/2025 07:34 PM • Fiserv announced significant leadership changes and financial recalibration in Q3 2025, resulting in a sharp stock price decline and $32 billion shareholder value loss after revealing overly optimistic prior growth assumptions.

FI - Company reported sequential revenue decline, slashed growth expectations, replaced key leadership, and experienced a massive $32 billion market value reduction after revealing problematic prior financial projections

#securities investigation #financial performance #leadership changes #revenue decline

Amazon Strikes $38B OpenAI Deal, Wedbush Hikes Target To Street-High

Benzinga • Erica Kollmann

Amazon Strikes $38B OpenAI Deal, Wedbush Hikes Target To Street-High

11/03/2025 07:28 PM • Amazon announced a $38 billion multi-year partnership with OpenAI to provide cloud computing infrastructure, with Wedbush analysts raising Amazon's price target to $340, signaling strong potential in AI cloud services.

NMHI - Gained global rights to integrate advanced blockchain-based carbon credit tokenization technology, enhancing their environmental technology platform
AMZN - Secured major AI infrastructure deal with OpenAI, received price target increase, showing strong growth potential in cloud services

#AWS #AI #cloud computing #partnership #infrastructure

Kayne Anderson Energy Infrastructure Fund Provides Unaudited Balance Sheet Information and Announces Its Net Asset Value and Asset Coverage Ratios as of October 31, 2025

GlobeNewswire Inc. • Kayne Anderson

Kayne Anderson Energy Infrastructure Fund Provides Unaudited Balance Sheet Information and Announces Its Net Asset Value and Asset Coverage Ratios as of October 31, 2025

11/03/2025 06:45 PM • Kayne Anderson Energy Infrastructure Fund reported $2.2 billion in net assets as of October 31, 2025, with a net asset value per share of $13.13. The fund's investment portfolio is primarily focused on Midstream Energy Companies, with top holdings including Williams Companies, Enterprise Products Partners, and Energy Transfer LP.

WMB - Largest holding in the fund at 10.6% of long-term investments, indicating strong confidence in the company

#energy infrastructure #midstream #investment fund #financial report

Palantir CEO Alex Karp Just Delivered Incredible News for Nvidia Stock Investors

The Motley Fool • Danny Vena

Palantir CEO Alex Karp Just Delivered Incredible News for Nvidia Stock Investors

11/03/2025 06:32 PM • Palantir Technologies reported strong Q3 results, demonstrating continued AI adoption and growth, which provides positive signals for Nvidia's AI chip market prospects. The company's commercial segment saw significant revenue acceleration and customer growth, indicating the ongoing AI revolution.

NMHI - Gaining access to advanced blockchain infrastructure for carbon credit verification, expanding environmental impact, and strategically positioning in Asian markets
PLTR - Reported 63% year-over-year revenue growth, 110% increase in adjusted EPS, and 121% revenue acceleration in commercial segment

#AI #artificial intelligence #data centers #technology #enterprise adoption

Michael Burry Is Super-Bearish On Palantir — With 5 Million Puts

Benzinga • Erica Kollmann

Michael Burry Is Super-Bearish On Palantir — With 5 Million Puts

11/03/2025 06:17 PM • Billionaire investor Michael Burry's hedge fund Scion Asset Management purchased 5 million put options on Palantir and 1 million put options on NVIDIA, signaling a bearish stance on these tech companies while also highlighting potential concerns about an AI investment bubble.

PLTR - Burry purchased 5 million put options worth $912.1 million, indicating a strong bearish outlook on the company's future performance

#Michael Burry #Palantir #NVIDIA #put options #AI bubble #hedge fund